2019 Cancer Council Update Series
Workplace Chemicals and Cancer: How are they identified and managed
On the 4th of December 2019, John Frangos, a fellow of the Australasian College and Risk Assessment gave a lecture on Workplace chemicals and cancer. Although occupational related cancers can arise from a large variety of occupational exposures, three cancers (lung cancer, leukaemia and malignant mesothelioma) account for most of the burden of disease. This presentation talked about the scientific basics of common occupational carcinogens and also the regulatory aspects of hazard and risk assessment. That is how carcinogens are classified by international agencies such as the International Agency for Research on Cancer and how these classification processes can differ with national agencies. The presentation will also provided a historical approach to setting occupational exposure limits and how these are used in workplace control. The examples used include benzene, diesel exhaust, asbestos and vinyl chloride.
Intervening early to support families after child and adolescent cancer: a focus on community
On 24 October 2019, Dr Ursula Sansom-Daly gave a lecture on supporting families after child adolescent cancer. Dr Sansom-Daly is the Deputy Head, Behavioural Sciences Unit, Sydney Children's Hospital - the largest research unit dedicated to paediatric/adolescent psycho-oncology in the southern hemisphere. She is also the Clinical Psychologist for Sydney Youth Cancer Service, the leading clinical team for the treatment and care of adolescents and young adults aged 15-25 years with cancer in Sydney.
Mesothelioma: new developments in the lab and the clinic
On 19 August 2019, Dr (Willem) Joost Lesterhuis discussed how mesothelioma arises, what symptoms it causes, how it is treated and what is currently being done in terms of research in the lab and the clinic. He also covered how findings from this research can be applied to other cancers.
Prevention and early detection of bowel cancer
On 30 July 2019, Dr Hooi Ee, Gastroenterologist at Sir Charles Gairdner Hospital, discussed what bowel cancer is, why Australia has one of the highest rates of bowel cancer in the world, and what you can do to reduce your risk.
Cancer immunotherapy for melanoma "The current state of play with immunotherapy treatments"
On 24 January 2019, Dr Ryan Sullivan gave a presentation on about what immunotherapy is and how it has impacted the care of patients with melanoma and will touch upon the types of treatments, how they are used, and what the downsides are. Dr Ryan Sullivan is an Assistant Professor, Medicine, Harvard Medical School & Assistant Professor, Haematology/Oncology, Massachusetts General Hospital.